Fungi belonging to the class Zygomycetes and order Mucorales are opportunistic pathogens, causing acute, angioinvasive infections that are rapidly fatal. Rhizopus, Mucor, Rhizomucor, Lichtheimia, Apophysomyces, Cunninghamella, and Saksenaea are some of the common causative agents involved.
The incidence of mucormycosis has increased globally over the past decades but the rise in developing countries including India has been phenomenal. Significant differences have been noted in the epidemiology of this disease in developed versus developing countries.
Mucormycosis remains a challenge to diagnose and treat and exhibits a high mortality rate, ranging from 50 to nearly 100%, especially in cases with disseminated disease, pulmonary infections, or cerebral involvement. Despite such a substantial impact, the pathogenesis of this disease is not yet fully understood, and limited diagnostic and treatment options are presently available.
This Research Topic aims to explore the advances and innovations relevant to mucormycosis, focusing on diverse aspects of this disease, such as pathobiology, diagnostic modalities, prophylactic measures, and therapeutic interventions.
We welcome submissions of Original Research, Methods, Review, Mini Review, Hypothesis and Theory, Perspective, and Brief Research Report articles, covering different facets of mucormycosis, including research advances in pathogenesis and immune response, diagnostics, biomarkers, preventive measures, and treatment aspects.
Fungi belonging to the class Zygomycetes and order Mucorales are opportunistic pathogens, causing acute, angioinvasive infections that are rapidly fatal. Rhizopus, Mucor, Rhizomucor, Lichtheimia, Apophysomyces, Cunninghamella, and Saksenaea are some of the common causative agents involved.
The incidence of mucormycosis has increased globally over the past decades but the rise in developing countries including India has been phenomenal. Significant differences have been noted in the epidemiology of this disease in developed versus developing countries.
Mucormycosis remains a challenge to diagnose and treat and exhibits a high mortality rate, ranging from 50 to nearly 100%, especially in cases with disseminated disease, pulmonary infections, or cerebral involvement. Despite such a substantial impact, the pathogenesis of this disease is not yet fully understood, and limited diagnostic and treatment options are presently available.
This Research Topic aims to explore the advances and innovations relevant to mucormycosis, focusing on diverse aspects of this disease, such as pathobiology, diagnostic modalities, prophylactic measures, and therapeutic interventions.
We welcome submissions of Original Research, Methods, Review, Mini Review, Hypothesis and Theory, Perspective, and Brief Research Report articles, covering different facets of mucormycosis, including research advances in pathogenesis and immune response, diagnostics, biomarkers, preventive measures, and treatment aspects.
